o-1057 o-1057 o-1057 is an analgesic cannabinoid derivative created by organix inc., newburyport, massachusetts, for use in scientific research. unlike most cannabinoids discovered to date, it is water-soluble, which gives it considerable advantages over many related cannabinoids. it has moderate affinity for both cb1 and cb2 receptors, with ki values of 8.36 nm at cb1 and 7.95 nm at cb2 o-1057identifiers iupac name 3-(5'-cyano-1',1'-dimethylpentyl)-1-(4-n-morpholinobutyryloxy)-δ8-tetrahydrocannabinol pubchem cid9829239chemspider8004975chemical and physical dataformulac32h46n2o4molar mass522.730 g·mol−13d model (jsmol)interactive image smiles n#cccccc(c3cc1oc(4c/c=c(\cc4c1c(oc(=o)cccn2ccocc2)c3)c)(c)c)(c)c inchi inchi=1s/c32h46n2o4/c1-23-11-12-26-25(20-23)30-27(37-29(35)10-9-15-34-16-18-36-19-17-34)21-24(22-28(30)38-32(26,4)5)31(2,3)13-7-6-8-14-33/h11,21-22,25-26h,6-10,12-13,15-20h2,1-5h3/t25-,26-/m1/s1key:yrdnbepfvbmtnp-cljljlngsa-n (verify)